ALC
Alcon AG
NYSE: ALC · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$72.81
-3.44% today
Updated 2026-04-29
Market cap
$36.39B
P/E ratio
36.77
P/S ratio
3.50x
EPS (TTM)
$1.98
Dividend yield
0.48%
52W range
$72 – $99
Volume
1.5M
Alcon AG (ALC) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2005 | 2006 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.37B | $4.90B | $6.52B | $6.60B | $6.79B | $7.15B | $7.51B | $6.83B | $8.29B | $8.72B | $9.46B | $9.91B | $10.40B |
| Revenue growth (YoY) | — | +12.1% | +33.1% | +1.2% | +3.0% | +5.3% | +5.0% | -9.0% | +21.3% | +5.1% | +8.5% | +4.8% | +4.9% |
| Cost of revenue | $1.08B | $1.22B | $3.39B | $3.48B | $3.59B | $3.96B | $3.85B | $3.89B | $3.64B | $3.97B | $4.21B | $4.40B | $4.66B |
| Gross profit | $3.29B | $3.68B | $3.12B | $3.11B | $3.20B | $3.19B | $3.66B | $2.94B | $4.65B | $4.75B | $5.25B | $5.51B | $5.75B |
| Gross margin | 75.3% | 75.2% | 47.9% | 47.2% | 47.2% | 44.6% | 48.8% | 43.0% | 56.1% | 54.5% | 55.5% | 55.6% | 55.2% |
| R&D | $421.80M | $512.10M | $440.56M | $499.00M | $584.00M | $587.00M | $656.00M | $673.00M | $842.00M | $702.00M | $859.00M | $876.00M | $990.00M |
| SG&A | — | — | — | $2.53B | $2.60B | $2.80B | $2.85B | $2.69B | $3.06B | $3.07B | $3.21B | $3.25B | $3.45B |
| Operating income | $1.19B | $1.57B | $401.12M | $10.00M | $-77.00M | $-248.00M | $-187.00M | $-482.00M | $580.00M | $672.00M | $1.04B | $1.41B | $1.36B |
| Operating margin | 27.2% | 32.1% | 6.2% | 0.2% | -1.1% | -3.5% | -2.5% | -7.1% | 7.0% | 7.7% | 11.0% | 14.3% | 13.1% |
| EBITDA | — | — | $1.57B | $1.17B | $1.22B | $1.35B | $1.26B | $1.18B | $1.76B | $1.78B | $2.24B | $2.68B | $2.35B |
| EBITDA margin | 0.0% | 0.0% | 24.0% | 17.7% | 17.9% | 18.9% | 16.7% | 17.3% | 21.2% | 20.4% | 23.7% | 27.0% | 22.6% |
| EBIT | $1.19B | $1.57B | $354.95M | $-79.48M | $-101.00M | $-274.00M | $-206.28M | $-542.60M | $539.14M | $616.59M | $1.02B | $1.45B | $1.16B |
| Interest expense | $38.80M | $42.60M | $17.31M | $30.05M | $27.00M | $23.83M | $134.44M | $131.67M | $120.26M | $138.40M | $189.00M | $186.18M | $204.00M |
| Income tax | $271.90M | $268.80M | $41.36M | $57.00M | $-383.00M | $-73.00M | $324.00M | $-104.00M | $42.00M | $128.00M | $-142.00M | $238.00M | — |
| Effective tax rate | 22.6% | 16.6% | 12.3% | -50.4% | 301.6% | 24.3% | -97.6% | 16.4% | 10.0% | 27.6% | -17.1% | 18.9% | 0.0% |
| Net income | $931.00M | $1.35B | $296.27M | $-170.00M | $256.00M | $-227.00M | $-656.00M | $-531.00M | $376.00M | $335.00M | $974.00M | $1.02B | $980.00M |
| Net income growth (YoY) | — | +44.8% | -78.0% | -157.4% | +250.6% | -188.7% | -189.0% | +19.1% | +170.8% | -10.9% | +190.7% | +4.5% | -3.7% |
| Profit margin | 21.3% | 27.5% | 4.5% | -2.6% | 3.8% | -3.2% | -8.7% | -7.8% | 4.5% | 3.8% | 10.3% | 10.3% | 9.4% |